SCHEMBL29324709

SCHEMBL29324709

CCOC(=O)CN1CCC2(CC1)CC(C(C)(C)C)C2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.44
ALDH1A1 P00352 2/20 0.44
CYP1A2 P05177 2/20 0.44
LMNA P02545 1/20 0.44
CYP3A4 P08684 1/20 0.44
GAA P10253 1/20 0.44
CYP2C9 P11712 1/20 0.44
ALOX12 P18054 1/20 0.44
CYP2C19 P33261 1/20 0.44
ELANE P08246 1/20 0.38
TDP1 Q9NUW8 1/20 0.34
GSK3A P49840 1/20 0.33
GSK3B P49841 1/20 0.33
CYP2D6 P10635 1/20 0.33
ALOX15 P16050 1/20 0.33
OPRM1 P35372 1/20 0.33
OPRD1 P41143 1/20 0.33
OPRK1 P41145 1/20 0.33
S1PR5 Q9H228 1/20 0.32
HTR1A P08908 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29324715 0.87 LMNA (0.39) KDM4EALDH1A1CYP1A2LMNACYP3A4
SCHEMBL14671169 0.81 ELANE (0.42) KDM4EALDH1A1LMNAGAAELANE
SCHEMBL29326427 0.80 ITGB3 (0.42) CYP1A2CYP2D6ALOX15HSD11B1
SCHEMBL29324706 0.80 CYP2D6 (0.37) ALDH1A1CYP1A2CYP2C19CYP2D6ALOX15
SCHEMBL17282182 0.80 GAA (0.49) KDM4EALDH1A1CYP1A2LMNACYP3A4
SCHEMBL14671159 0.79 KDM4E (0.40) KDM4EALDH1A1LMNAGAAELANE
SCHEMBL25477020 0.76 KDM4E (0.34) KDM4EALDH1A1CYP1A2LMNACYP3A4
SCHEMBL14671150 0.75 ELANE (0.40) KDM4EALDH1A1LMNAGAAELANE
SCHEMBL26148188 0.75 CYP2D6 (0.42) CYP3A4CYP2D6
SCHEMBL25039502 0.75 ELANE (0.42) KDM4EALDH1A1GAAELANETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239792-A1 MODULATORS OF BCL-2 OR BCL-2/BCL-XL AND USES THEREOF ASIA VISION LIMITED (CN) 2024-07-18 US disclosed
US-20240239792-A1 MODULATORS OF BCL-2 OR BCL-2/BCL-XL AND USES THEREOF ASIA VISION LIMITED (CN) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239792-A1 MODULATORS OF BCL-2 OR BCL-2/BCL-XL AND USES THEREOF BCL2, BCL2L2, BCL2L1 KDM4E 3505/4885ALDH1A1 3682/4885CYP1A2 3232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.